These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2805869)

  • 1. Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects.
    Gross NJ; Co E; Skorodin MS
    Chest; 1989 Nov; 96(5):984-7. PubMed ID: 2805869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of anticholinergic bronchodilators in adult asthma and chronic obstructive pulmonary disease.
    Chapman KR
    Lung; 1990; 168 Suppl():295-303. PubMed ID: 2143551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oral corticosteroids on bronchodilator responses in COPD.
    Corden Z; Rees PJ
    Respir Med; 1998 Feb; 92(2):279-82. PubMed ID: 9616526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic bronchodilators in obstructive airway disease.
    Karpel JP
    J Assoc Acad Minor Phys; 1991; 2(3):118-22. PubMed ID: 1839720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease.
    Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM
    Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1.
    Dompeling E; van Schayck CP; Molema J; Akkermans R; Folgering H; van Grunsven PM; van Weel C
    Eur Respir J; 1992 Sep; 5(8):975-81. PubMed ID: 1426206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bronchomotor tone and gas density on time dependence of forced expiratory vital capacity maneuver.
    D'Angelo E; Milic-Emili J; Marazzini L
    Am J Respir Crit Care Med; 1996 Nov; 154(5):1318-22. PubMed ID: 8912742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
    Anthonisen NR; Connett JE; Kiley JP; Altose MD; Bailey WC; Buist AS; Conway WA; Enright PL; Kanner RE; O'Hara P
    JAMA; 1994 Nov; 272(19):1497-505. PubMed ID: 7966841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinergic agents in COPD.
    Gross NJ
    Chest; 1987 May; 91(5 Suppl):52S-57S. PubMed ID: 3552471
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the parasympathetic system in airway obstruction due to emphysema.
    Gross NJ; Skorodin MS
    N Engl J Med; 1984 Aug; 311(7):421-5. PubMed ID: 6749189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the parasympathetic system in the regulation of bronchial smooth muscle.
    Boushey HA
    Eur J Respir Dis Suppl; 1984; 135():80-90. PubMed ID: 6145616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic, antimuscarinic bronchodilators.
    Gross NJ; Skorodin MS
    Am Rev Respir Dis; 1984 May; 129(5):856-70. PubMed ID: 6372560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.
    Rutgers SR; Koëter GH; van der Mark TW; Postma DS
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):880-6. PubMed ID: 9517606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute bronchodilator responses to β2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation.
    Konno S; Makita H; Suzuki M; Shimizu K; Kimura H; Kimura H; Nishimura M;
    Respir Med; 2017 Jun; 127():14-20. PubMed ID: 28502414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group.
    Kerstjens HA; Overbeek SE; Schouten JP; Brand PL; Postma DS
    Eur Respir J; 1993 Jun; 6(6):868-76. PubMed ID: 8339808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in pulmonary medicine. Patients with COPD should be started initially on anticholinergic bronchodilators.
    Chapman KR; Wanner A
    Am Rev Respir Dis; 1988 Oct; 138(4):1074-5. PubMed ID: 2904777
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.
    Pauwels RA; Löfdahl CG; Laitinen LA; Schouten JP; Postma DS; Pride NB; Ohlsson SV
    N Engl J Med; 1999 Jun; 340(25):1948-53. PubMed ID: 10379018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
    Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.